Related Experiment Video
Updated: Jul 15, 2026

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community
Francesco Landi1, Andrea Russo, Ettore Capoluongo
1Department of Gerontology and Geriatrics, Catholic University of Sacred Heart, Roma, Italy. francesco_landi@rm.unicatt.it
Insights
Higher levels of insulin-like growth factor-binding protein 3 (IGFBP-3) are linked to increased hemoglobin concentration in older adults. This suggests the growth hormone/IGF axis influences red blood cell production in the elderly.
Area of Science:
- Gerontology
- Endocrinology
- Hematology
Background:
- Anemia is common in the elderly, often with unknown causes.
- Understanding factors influencing hemoglobin levels in older adults is crucial for health.
- The role of the growth hormone/IGF axis in aging and hematopoiesis requires further investigation.
Purpose of the Study:
- To investigate the association between insulin-like growth factor-binding protein 3 (IGFBP-3) levels and hemoglobin concentration in individuals aged 80 and above.
- To explore the potential role of the growth hormone/IGF axis in age-related changes in hemoglobin.
Main Methods:
- Cross-sectional analysis of baseline data from the ilSIRENTE study (n=253).
- Utilized analysis of covariance to assess the relationship between IGFBP-3 levels and hemoglobin.
- Adjusted for confounding factors including age, sex, comorbidities, renal function, albumin, and iron levels.
Main Results:
- Higher IGFBP-3 concentrations were significantly associated with higher mean hemoglobin levels (13.4 +/- 1.4 g/dL vs. 12.9 +/- 1.9 g/dL, P=.03) after statistical adjustments.
- The association remained significant even after accounting for various clinical and biochemical variables.
Conclusions:
- Elevated IGFBP-3 levels correlate with increased hemoglobin concentration in community-dwelling older adults.
- The growth hormone/IGF axis may play a significant role in regulating hematopoiesis in the elderly.
- This finding could offer insights into the mechanisms behind age-related anemia.
Abstract:
A decreased hemoglobin concentration is a common clinical condition in elderly subjects, and in at least 20% of the cases it is not possible to directly attribute the anemia to specific factors. The aim of the present study was to evaluate the relationship of different levels of insulin-like growth factor-binding protein 3 (IGFBP-3) with the blood concentration of hemoglobin in persons aged 80 years and older. Data are from a baseline evaluation of the Aging and Longevity in the Sirente Geographic Area (ilSIRENTE) study (n=253). Analysis of covariance was used to examine the effect of different IGFBP-3 levels on hemoglobin concentration. After adjustment for potential confounding variables, which included age, sex, number of diseases, renal failure, cancer, gastric ulcer, albumin, and iron concentrations, individuals in the group with higher IGFBP-3 concentrations showed a significantly higher mean hemoglobin concentration than participants in the group with lower IGFBP-3 concentrations (13.4 +/- 1.4 g/dL versus 12.9 +/- 1.9 g/dL, respectively; P=.03). In conclusion, the present study has shown that a higher IGFBP-3 level is associated with a higher hemoglobin concentration among older people living in the community. This finding suggests that the growth hormone/IGF axis may play an important role in hematopoiesis, and it may be implicated in the age-related decline in hemoglobin concentration.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Oxygen Transport in the Blood
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion